kyoto.jpeg

kyoto

kyotovisitorshost.jpeg

kyotovisitorshost

General information

Announcements(0)

Overview

Pre-registration

Abstract Submission (Oral/Poster Presentation)

Guidelines for Writing Abstracts (Oral/Poster Pres

Program

Sessions

Search presentations

pharm140_e.png

icon_20251203154432448.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

Messenger RNA for cell editing - Disease treatment and cell transplantation using pro-survival mRNA

Recently, the scope of the medicine has been expanding, and living cells have been clinically used as a pharmaceutical drug. For the effective development of cell-based medicine, one of the key issues is to manipulate living cell function, particularly in vivo. To achieve this goal, it is essential to collaborate multidisciplinary among bio-engineering and medicine over the fields of pharmaceutical sciences. In this symposium, we define "artificial modification and/or control of cell function" as "cell editing", and focus on developing new materials and utilizing those materials both in cultured cells and body. Actually, "cell editing" involves a variety of approaches based on molecular-biology, engineering materials, cell-surface engineering, and scaffold-technology, furthermore, understanding and developing a model of the microenvironment in disease tissues. In this symposium, we invite active young researchers who develop the important technologies for "cell editing", e.g., new material technologies to create artificial organelles, cutting-edge technologies for in vivo functional nucleic acid delivery, bio-interface control technologies based on polymer-based biomaterials, novel disease models based on 3D-culture system as a tool for artificial cell function tuning, practical methods for in vivo cell editing and cell transplantation using mRNA, in vivo cell delivery using cell surface engineering. We will discuss how to tackle the issue to achieve "in vivo cell editing" from the multidisciplinary viewpoint.

Cell editing: Control of cell function utilizing biomaterials based on collaborative researches between medicine, pharmaceutical sciences, and engineering

The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)

Presentation Information

[S16-5]Messenger RNA for cell editing - Disease treatment and cell transplantation using pro-survival mRNA

Password required to view